Epilepsy & Seizures

Filter Your Results

 

News

 

New Data Highlight Efficacy and Safety of Brain Responsive Neuromodulation for Reduction of Seizures

Wednesday, May 03, 2017—Two new studies offer long-term perspective on the efficacy and safety of brain responsive neuromodulation for the reduction of seizures. One study evaluated the effects of Ne…

AAN Unveils New Guideline for SUDEP at Annual Meeting

Tuesday, April 25, 2017—The American Academy of Neurology (AAN) and the American Epilepsy Society (AES) have released a new joint guideline for sudden unexpected death in epilepsy (SUDEP) at the AAN …

The Utility of EEG in Prognosis Post-Cardiac Arrest

Michelle Dougherty, MD

April 2017—EEG findings are helpful at either end of the spectrum, but more research is needed before it can be used more broadly to determine prognosis for patients with cardiac arrest.

Review Identifies Antidepressants and AEDs Effective for Nerve Pain

Friday, March 24, 2017—A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain. In findings published in the…

Sunovion Submits NDA to Expand Aptiom Indication to Pediatric Patients

Tuesday, March 14, 2017—Sunovion Pharmaceuticals has submitted a supplemental new drug application (sNDA) to the FDA to expand the indication for its antiepileptic drug AED Aptiom (eslicarbazepine ac…

Takeda and Ovid Strike Partnership to Develop Investigational Agent for Rare Pediatric Epilepsy

Thursday, January 19, 2017—Takeda and Ovid Therapeutics are teaming up for the clinical development and commercialization of Takeda’s investigational new drug TAK-935, a novel CH24H inhibitor, in …

NeuroPace Unveils New Long-Term Data for Its RNS System

Friday, December 09, 2016—At the recent American Epilepsy Society Annual Meeting in Houston, NeuroPace shared new long-term data for its RNS System for the treatment of partial-onset seizure. The RNS S…

Reflecting on New Phase 3 Epidiolex Data, GW Pharmaceuticals CEO Emphasizes Education About Cannabidiol

Thursday, December 08, 2016—Greenwich Biosciences, a subsidiary of GW Pharmaceuticals, shared phase 3 data in poster presentations at the recent American Epilepsy Society Annual Meeting showing that it&r…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC